secwatch / observer
8-K filed March 9, 2023, 6:59 PM ET ticker GTHP CIK 0000924515
leadership confidence high sentiment neutral materiality 0.55

Guided Therapeutics CEO Gene Cartwright retires; Mark Faupel appointed as successor

GUIDED THERAPEUTICS INC

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alan Grujic

Director
GTHP · GUIDED THERAPEUTICS INC
Effective
2023-03-08
Successor
Gene Cartwright
Filed
March 9, 2023, 6:59 PM ET
the Board appointed Mr. Alan Grujic to replace Mr. Cartwright on the Board, effective March 8, 2023.
Departed

Gene Cartwright

President and Chief Executive Officer
GTHP · GUIDED THERAPEUTICS INC
Effective
2023-03-03
Successor
Mark Faupel
Filed
March 9, 2023, 6:59 PM ET
Dr. Gene Cartwright notified the Board of Directors (the “ Board ”) of Guided Therapeutics, Inc. (the “ Company ”) of his intent to retire from his position as President and Chief Executive Officer of the Company and as a member of the Board, effective immediately.
Appointed

Mark Faupel

President and Chief Executive Officer
GTHP · GUIDED THERAPEUTICS INC
Effective
2023-03-06
Filed
March 9, 2023, 6:59 PM ET
the Board appointed Dr. Mark Faupel, Ph.D., 67, the Company’s Chief Operating Officer since December 2016, to replace Mr. Cartwright as the Company’s President and Chief Executive Officer, effective as of March 6, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alan Grujic was appointed as Director at GUIDED THERAPEUTICS INC.

Action
appointed
Role
Director
Exact text from the filing
the Board appointed Mr. Alan Grujic to replace Mr. Cartwright on the Board, effective March 8, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gene Cartwright retired as President and Chief Executive Officer at GUIDED THERAPEUTICS INC.

Action
retired
Role
President and Chief Executive Officer
Exact text from the filing
Dr. Gene Cartwright notified the Board of Directors (the “ Board ”) of Guided Therapeutics, Inc. (the “ Company ”) of his intent to retire from his position as President and Chief Executive Officer of the Company and as a member of the Board, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Faupel was appointed as President and Chief Executive Officer at GUIDED THERAPEUTICS INC.

Action
appointed
Role
President and Chief Executive Officer
Exact text from the filing
the Board appointed Dr. Mark Faupel, Ph.D., 67, the Company’s Chief Operating Officer since December 2016, to replace Mr. Cartwright as the Company’s President and Chief Executive Officer, effective as of March 6, 2023.
View on SEC.gov

GUIDED THERAPEUTICS INC filing history →

Source: SEC EDGAR
accession 0001477932-23-001383
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.